LONA
LeonaBio, Inc.
Key Financials
Operating Income
$-102266000
↓ 1.4%
Net Income
$-105609000
↓ 8.9%
Total Liabilities
$64.4M
↑ 361.8%
EPS (Diluted)
$-24.70
↓ 880.2%
Cash & Equivalents
$69.3M
↑ 43.0%
Total Assets
$92.2M
↑ 56.8%
Shareholders' Equity
$27.8M
↓ 38.0%
Operating Cash Flow
$-45729000.00
↑ 52.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G | 5/15/2026 | View on SEC |
| ARS | 5/11/2026 | View on SEC |
| DEFA14A | 5/11/2026 | View on SEC |
| DEF 14A | 5/11/2026 | View on SEC |
| 4 | 5/7/2026 | View on SEC |
| 4 | 5/7/2026 | View on SEC |
| 4 | 5/7/2026 | View on SEC |
| 3 | 5/7/2026 | View on SEC |
| 3 | 5/7/2026 | View on SEC |
| 3 | 5/7/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | LONA |
| Company Name | LeonaBio, Inc. |
| CIK | 1620463 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | (425) 620-8501 |